Michael Felice

Papers

Total Citations

H-Index

About

Michael Felice is a pioneering urologic surgeon whose work centers on advancing minimally invasive prostate cancer surgery, with a particular focus on optimizing patient outcomes through innovative robotic techniques. His major contribution lies in the clinical validation and refinement of Retzius-sparing prostatectomy, a procedure that preserves critical anatomical structures to improve early recovery of urinary continence. In his landmark 2023 study, "Transition from standard robotic prostatectomy to Retzius-sparing prostatectomy: feasibility and early outcomes," Felice demonstrated the practical viability of shifting from conventional robotic methods to this nerve-sparing approach, reporting favorable early results that have already garnered 8 citations and sparked broader adoption. His research bridges the gap between surgical innovation and real-world application, offering urologists a reproducible framework for reducing postoperative complications without compromising oncologic control. Felice’s work is particularly notable for its emphasis on feasibility—proving that complex surgical transitions can be safely implemented in high-volume centers. By systematically documenting outcomes, he provides a roadmap for peers seeking to enhance quality of life for prostate cancer patients. His contributions underscore a commitment to evidence-based evolution in robotic surgery, making him a key voice in the ongoing refinement of prostate cancer care.